Human Immunology ELISA Kits 1
Human LILRB2 (Leukocyte Immunoglobulin Like Receptor Subfamily B Member 2) CLIA Kit (HUES00886)
- SKU:
- HUES00886
- Product Type:
- ELISA Kit
- ELISA Type:
- CLIA Kit
- Size:
- 96 Assays
- Sensitivity:
- 18.75pg/mL
- Range:
- 31.25-2000pg/mL
- ELISA Type:
- Sandwich
- Synonyms:
- CD85D, ILT4, LILRA6, LIR-2, LIR2, MIR-10, MIR10
- Reactivity:
- Human
- Sample Type:
- Serum, plasma and other biological fluids
- Research Area:
- Immunology
Description
Assay type: | Sandwich |
Format: | 96T |
Assay time: | 4.5h |
Reactivity: | Human |
Detection method: | Chemiluminescence |
Detection range: | 31.25-2000 pg/mL |
Sensitivity: | 18.75 pg/mL |
Sample volume: | 100µL |
Sample type: | Tissue homogenates |
Repeatability: | CV < 15% |
Specificity: | This kit recognizes Human LILRB2 in samples. No significant cross-reactivity or interference between Human LILRB2 and analogues was observed. |
This kit uses Sandwich-CLIA as the method. The micro CLIA plate provided in this kit has been pre-coated with an antibody specific to Human LILRB2. Standards or samples are added to the appropriate micro CLIA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human LILRB2 and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well successively and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human LILRB2, biotinylated detection antibody and Avidin-HRP conjugate will appear fluorescence. The Relative light unit (RLU) value is measured spectrophotometrically by the Chemiluminescence immunoassay analyzer. The RLU value is positively associated with the concentration of Human LILRB2. The concentration of Human LILRB2 in the samples can be calculated by comparing the RLU of the samples to the standard curve.
UniProt Protein Function: | LILRB2: Receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles. Involved in the down-regulation of the immune response and the development of tolerance. Competes with CD8A for binding to class I MHC antigens. Inhibits FCGR1A-mediated phosphorylation of cellular proteins and mobilization of intracellular calcium ions. 2 isoforms of the human protein are produced by alternative splicing. |
UniProt Protein Details: | Protein type:Membrane protein, integral; Receptor, misc. Chromosomal Location of Human Ortholog: 19q13. 4 Cellular Component: extracellular space; cell surface; membrane; integral to plasma membrane; cytoplasm; plasma membrane Molecular Function:protein binding; MHC class I protein binding; cell adhesion molecule binding; receptor activity; protein phosphatase 1 binding; inhibitory MHC class I receptor activity Biological Process: immune response-inhibiting cell surface receptor signaling pathway; negative regulation of calcium ion transport; regulation of immune response; positive regulation of regulatory T cell differentiation; negative regulation of immune response; positive regulation of interleukin-6 production; signal transduction; positive regulation of tolerance induction; heterotypic cell-cell adhesion; cell surface receptor linked signal transduction; negative regulation of T cell proliferation; cell-cell signaling; negative regulation of antigen processing and presentation; cellular defense response; positive regulation of T cell proliferation; Fc receptor mediated inhibitory signaling pathway; immune response; positive regulation of T cell tolerance induction |
NCBI Summary: | This gene is a member of the leukocyte immunoglobulin-like receptor (LIR) family, which is found in a gene cluster at chromosomal region 19q13. 4. The encoded protein belongs to the subfamily B class of LIR receptors which contain two or four extracellular immunoglobulin domains, a transmembrane domain, and two to four cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs). The receptor is expressed on immune cells where it binds to MHC class I molecules on antigen-presenting cells and transduces a negative signal that inhibits stimulation of an immune response. It is thought to control inflammatory responses and cytotoxicity to help focus the immune response and limit autoreactivity. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008] |
UniProt Code: | Q8N423 |
NCBI GenInfo Identifier: | 311033485 |
NCBI Gene ID: | 10288 |
NCBI Accession: | Q8N423. 4 |
UniProt Secondary Accession: | Q8N423,O75017, Q8NHJ7, Q8NHJ8, A8MU67, C9JF29, |
UniProt Related Accession: | Q8N423 |
Molecular Weight: | 51,959 Da |
NCBI Full Name: | Leukocyte immunoglobulin-like receptor subfamily B member 2 |
NCBI Synonym Full Names: | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
NCBI Official Symbol: | LILRB2 |
NCBI Official Synonym Symbols: | ILT4; LIR2; CD85D; ILT-4; LIR-2; MIR10; MIR-10 |
NCBI Protein Information: | leukocyte immunoglobulin-like receptor subfamily B member 2 |
UniProt Protein Name: | Leukocyte immunoglobulin-like receptor subfamily B member 2 |
UniProt Synonym Protein Names: | CD85 antigen-like family member D; Immunoglobulin-like transcript 4; ILT-4; Monocyte/macrophage immunoglobulin-like receptor 10; MIR-10; CD_antigen: CD85d |
UniProt Gene Name: | LILRB2 |
UniProt Entry Name: | LIRB2_HUMAN |
As the RLU values of the standard curve may vary according to the conditions of the actual assay performance (e. g. operator, pipetting technique, washing technique or temperature effects), the operator should establish a standard curve for each test. Typical standard curve and data is provided below for reference only.
Concentration (pg/mL) | RLU | Average | Corrected |
2000 | 54739 56703 | 55721 | 55693 |
1000 | 23830 24118 | 23974 | 23946 |
500 | 12004 10060 | 11032 | 11004 |
250 | 5071 5517 | 5294 | 5266 |
125 | 2627 2589 | 2608 | 2580 |
62.5 | 1357 1265 | 1311 | 1283 |
31.25 | 638 710 | 674 | 646 |
0 | 27 29 | 28 | -- |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, mid range and high level Human LILRB2 were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, mid range and high level Human LILRB2 were tested on 3 different plates, 20 replicates in each plate.
Intra-assay Precision | Inter-assay Precision | |||||
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 93.76 | 263.95 | 925.19 | 87.48 | 257.17 | 1005.66 |
Standard deviation | 7.70 | 19.56 | 102.88 | 8.91 | 26.31 | 115.35 |
C V (%) | 8.21 | 7.41 | 11.12 | 10.19 | 10.23 | 11.47 |
Recovery
The recovery of Human LILRB2 spiked at three different levels in samples throughout the range of the assay was evaluated in various matrices.
Sample Type | Range (%) | Average Recovery (%) |
Serum (n=5) | 87-99 | 92 |
EDTA plasma (n=5) | 101-117 | 108 |
Cell culture media (n=5) | 91-106 | 97 |
Linearity
Samples were spiked with high concentrations of Human LILRB2 and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.
Serum (n=5) | EDTA plasma (n=5) | Cell culture media (n=5) | ||
1:2 | Range (%) | 90-101 | 88-102 | 92-110 |
Average (%) | 95 | 94 | 100 | |
1:4 | Range (%) | 97-115 | 99-115 | 96-110 |
Average (%) | 105 | 105 | 101 | |
1:8 | Range (%) | 95-107 | 96-108 | 90-104 |
Average (%) | 102 | 101 | 95 | |
1:16 | Range (%) | 85-97 | 85-100 | 101-116 |
Average (%) | 92 | 91 | 106 |
An unopened kit can be stored at 4°C for 1 month. If the kit is not used within 1 month, store the items separately according to the following conditions once the kit is received.
Item | Specifications | Storage |
Micro CLIA Plate(Dismountable) | 8 wells ×12 strips | -20°C, 6 months |
Reference Standard | 2 vials | |
Concentrated Biotinylated Detection Ab (100×) | 1 vial, 120 µL | |
Concentrated HRP Conjugate (100×) | 1 vial, 120 µL | -20°C(shading light), 6 months |
Reference Standard & Sample Diluent | 1 vial, 20 mL | 4°C, 6 months |
Biotinylated Detection Ab Diluent | 1 vial, 14 mL | |
HRP Conjugate Diluent | 1 vial, 14 mL | |
Concentrated Wash Buffer (25×) | 1 vial, 30 mL | |
Substrate Reagent A | 1 vial, 5 mL | 4°C (shading light) |
Substrate Reagent B | 1 vial, 5 mL | 4°C (shading light) |
Plate Sealer | 5 pieces | |
Product Description | 1 copy | |
Certificate of Analysis | 1 copy |
- Set standard, test sample and control (zero) wells on the pre-coated plate and record theirpositions. It is recommended to measure each standard and sample in duplicate. Note: addall solutions to the bottom of the plate wells while avoiding contact with the well walls. Ensuresolutions do not foam when adding to the wells.
- Aliquot 100µl of standard solutions into the standard wells.
- Add 100µl of Sample / Standard dilution buffer into the control (zero) well.
- Add 100µl of properly diluted sample (serum, plasma, tissue homogenates and otherbiological fluids. ) into test sample wells.
- Cover the plate with the sealer provided in the kit and incubate for 90 min at 37°C.
- Aspirate the liquid from each well, do not wash. Immediately add 100µL of BiotinylatedDetection Ab working solution to each well. Cover the plate with a plate seal and gently mix. Incubate for 1 hour at 37°C.
- Aspirate or decant the solution from the plate and add 350µL of wash buffer to each welland incubate for 1-2 minutes at room temperature. Aspirate the solution from each well andclap the plate on absorbent filter paper to dry. Repeat this process 3 times. Note: a microplatewasher can be used in this step and other wash steps.
- Add 100µL of HRP Conjugate working solution to each well. Cover with a plate seal andincubate for 30 min at 37°C.
- Aspirate or decant the solution from each well. Repeat the wash process for five times asconducted in step 7.
- Add 100µL of Substrate mixture solution to each well. Cover with a new plate seal andincubate for no more than 5 min at 37°C. Protect the plate from light.
- Determine the RLU value of each well immediately.